Brief: IVERIC bio reports Q4 net loss of USD 59.061 million.
01/03/2023 11:33
Mar 1 (Reuters) - IVERIC bio Q4 net income USD -59.061 million. * Q4 operating expenses USD 62.971 million
Recent news on IVERIC bio
See all newsBrief: Astellas Pharma Inc - Astellas Completes Acquisition Of Iveric Bio
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Iveric Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary
The end of cheap credit could hurry Japanese M&A
U.S. STOCKS ON THE MOVE-US banks, Biomea Fusion, Tutor Perini